ReviewThe Lancet regional health. Western Pacific2022
Towards Equitable Access to Public Health Pathogen Genomics in the Western Pacific.
Review in The Lancet regional health. Western Pacific, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- From concept to capability: CBRNE-grade, equity-first benchmarks for preventing HKU5-CoV-2 spillover.Infectious diseases & immunity · 2026Article
- A qualitative evaluation of access to essential laboratory services for communicable diseases at the primary health care level in the Western Pacific Region.Tropical medicine and health · 2025Article
- Communicable diseases genomics network: promoting and harmonising pathogen genomics implementation for public health in Australia.The Lancet regional health. Western Pacific · 2025Review
- Identifying factors that influence the use of pathogen genomics in Australia and New Zealand: a protocol.Frontiers in public health · 2024Article
- Towards a post-pandemic future for global pathogen genome sequencing.PLoS biology · 2023Article
- The importance of equally accessible genomic surveillance in the age of pandemics.Biologia futura · 2023Review
- Article
- The COVID-19 laboratory response in Timor-Leste; a story of collaboration.The Lancet regional health. Southeast Asia · 2023Review
- The Prevalence ofMicroorganisms · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The COVID-19 pandemic has increased interest and understanding of the utility of pathogen genomics across the Western Pacific region. Access to genomic data enhances surveillance and response to COVID-19, and will also support surveillance of other infectious diseases and antimicrobial resistant pathogens. Models of access can be determined based on intended purpose, use and sustainability. Achieving equitable access to genomics across the Western Pacific will contribute to the development of a regional public health genomics network to respond to major disease threats in the future.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.